In 100 years, medicine is likely to be vastly different to what we can predict – or even imagine.

Initial research into the uses of medical cannabis suggests applications across a range of diseases, but research is needed to realize cannabis’ full medical potential.

Over the past 200 years JM has established itself as a world leader within the Pharma industry

Nasal-bound nanoparticles could offer a novel way to bypass the blood-brain barrier

As Article 50's clock continues to tick, will the UK reconsider EEA/EFTA membership?

Boosting the body's built-in cannabinoid signaling receptors

The International Cannabinoid Research Society was formed in the early 1990s – and continues to grow

How will pharmacovigliance in the UK and Europe be affected by Brexit?

Patheon's Steve Lam shares his lessons learned over three decades in bioprocessing.

What do trends in small molecule drugs mean for contract manufacturers?